A Cell-Based Drug Delivery System for Lung Targeting: II. Therapeutic Activities on B16-F10 Melanoma in Mouse Lungs
Open Access
- 1 January 2001
- journal article
- research article
- Published by Taylor & Francis in Drug Delivery
- Vol. 8 (2) , 71-76
- https://doi.org/10.1080/107175401750177007
Abstract
The in vitro and in vivo anticancer activities of doxorubicin-loaded B16-F10 murine melanoma cells (DLTC) were evaluated. DLTC showed similar growth-inhibitory effects against live B16-F10 cells with doxorubicin solution in cell culture system, with the IC50Keywords
This publication has 12 references indexed in Scilit:
- Mitoxantrone, etoposide and ara‐C vs doxorubicin‐DNA, ara‐C, thioguanine, vincristine and prednisolone in the treatment of patients with acute myelocytic leukaemia. A randomized comparisonEuropean Journal of Haematology, 1995
- Antibody-Targeted Drugs for the Therapy of CancerJournal of Drug Targeting, 1994
- Liposomes as Carriers of Cancer ChemotherapyDrugs, 1993
- Adhesion molecules and tumor cell interaction with endothelium and subendothelial matrixCancer and Metastasis Reviews, 1992
- Current state of liposome-complexed drugs in the treatment of cancer patientsAnnals of Oncology, 1992
- Inhibition of human renal cancer by monoclonal antibody targeted methotrexate-containing liposomes in an ascites tumor modelCancer Letters, 1991
- Organ-preference of metastasisCancer and Metastasis Reviews, 1990
- Endogenous galactoside-binding lectins: a new class of functional tumor cell surface molecules related to metastasisCancer and Metastasis Reviews, 1987
- Clonal Origin of Metastasis in B16 Murine Melanoma: A Cytogenetic Study23JNCI Journal of the National Cancer Institute, 1987
- Organ-Specific Adhesion of Metastatic Tumor Cells in VitroScience, 1984